Sickle Cell Disease, Hemolytic Anemia
1 clinical trials · Condition
◉ Watch Sickle Cell Disease, Hemolytic Anemia
| Record | Firm | Date |
|---|---|---|
| Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease (NCT07566494) | National Heart, Lung, and Blood Institute (NHLBI) | 2026-07-31 |
Track Sickle Cell Disease, Hemolytic Anemia automatically
Every clearance here is in the API, with alerts when new ones post.